Alexion Pharmaceuticals, Inc. (ALXN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)

ALXN 182.50

0.0%

Jul 28 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (298)	8/5/2003 5:43:50 PM
From: Ian@SI	Read Replies (1) of 824

After the conf call, I'd almost expected the stock to be up 20%. One of Lenny's comments was that, "Most of the development risk/cost for Pex is behind us." (Me paraphrasing from memory rather than an exact word for word quote). I'm left with the impression that Pex could still be approved within the originally targetted time and probably end up with a broader label than expected (both CABG and CABH-Valve). Essentially if one liked the stock yesterday morning, they should like it even more today. But then you have idiots like Mike Huckman on CNBC whose total research seems to be reading the headline of the press release. FWIW, Ian

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next